경보디앤씨

비상장계속사업자

kyungbodnc

박오순

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

경보디앤씨

Business Reg. No. 1248653563 · CEO 박오순

I.Investment Overview

Target경보디앤씨 (1248653563)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명경보디앤씨
영문명kyungbodnc
대표자박오순
사업자등록번호1248653563
법인등록번호1348110136011
설립일2007.03.15

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW218.620192.7202037.820229.520240.92025
영업이익100M KRW54.22019-7.220208.920220.12024-3.62025
순이익100M KRW41.72019-17.220206.620220.120240.62025
Item20252024202220202019
자산총계157.2억원153.7억원105.8억원100.8억원154.1억원
부채총계90.5억원87.6억원37.7억원77.8억원113.9억원
자본총계66.7억원66.1억원68.1억원23.1억원40.2억원
매출액8,844만원9.5억원37.8억원2.7억원218.6억원
영업이익-3.6억원959만원8.9억원-7.2억원54.2억원
순이익6,073만원681만원6.6억원-17.2억원41.7억원

VI.Financial Ratios

FY2025 basis

-407.61%

영업이익률

68.66%

순이익률

0.39%

ROA

0.91%

ROE

135.65%

부채비율

42.44%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

경보디앤씨 투심보고서 | Alpha Lenz